4//SEC Filing
Dingivan Christine A 4
Accession 0001440766-10-000001
CIK 0001003124other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:12 PM ET
Size
11.7 KB
Accession
0001440766-10-000001
Insider Transaction Report
Form 4
Dingivan Christine A
EVP/Chief Medical Officer
Transactions
- Award
Stock Option (to buy)
2010-02-25+40,000→ 40,000 totalExercise: $21.17From: 2011-02-25Exp: 2020-02-25→ Common Stock (40,000 underlying)
Holdings
- 7,500
Stock Options (to buy)
Exercise: $20.64From: 2009-11-20Exp: 2018-11-20→ Common Stock (7,500 underlying) - 90,000
Stock Options (to buy)
Exercise: $37.93From: 2009-07-28Exp: 2018-07-28→ Common Stock (90,000 underlying) - 30,000
Stock Options (to buy)
Exercise: $26.64From: 2010-02-18Exp: 2019-02-18→ Common Stock (30,000 underlying)
Footnotes (5)
- [F1]The options will vest in equal increments of 1/3 on February 25, 2011, February 25, 2012 and February 25, 2013.
- [F2]The options will vest in equal increments of 1/3 on February 18, 2010, February 18, 2011 and February 18, 2012.
- [F3]The options will vest in equal increments of 1/3 on November 20, 2009, November 20, 2010 and November 20, 2011.
- [F4]The options will vest in equal increments of 1/3 on October 3, 2009, October 3, 2010 and October 3, 2011.
- [F5]The options vest in equal increments of 1/3 on July 28, 2009, July 28, 2010 and July 28, 2011.
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeother
Related Parties
1- filerCIK 0001440766
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:12 PM ET
- Size
- 11.7 KB